1. Lipoprotein(a): Implications for clinical practice

   • Robert C. Block
   • Thomas A. Pearson

   Invited Commentary Pages: 327 - 329

2. Web alert

   Announcement Pages: 330 - 330

3. Clinical trials report

   • Peter P. Toth

   OriginalPaper Pages: 333 - 334

4. New insights in the treatment of dyslipidemia: A focus on cardiovascular event reduction and the antiatherosclerotic effects of atorvastatin

   • Peter P. Toth

   OriginalPaper Pages: 335 - 343

5. Hepatic high-density lipoprotein receptors: Roles in lipoprotein metabolism and potential for therapeutic modulation

   • Bernardo L. Trigatti

   OriginalPaper Pages: 344 - 350

6. Statins and proteinuria

   • Donald G. Vidt

   OriginalPaper Pages: 351 - 357

7. Evidence-based management of peripheral vascular disease

   • Nicolas W. Shammas
   • Eric J. Dippel

   OriginalPaper Pages: 358 - 363

8. The role of statins in the prevention of ischemic stroke

   • Bo Ziedén
   • Anders G. Olsson

   OriginalPaper Pages: 364 - 368

9. Impact of thiazolidinedione therapy on atherogenesis

   • Jeroen P. H. van Wijk
   • Ton J. Rabelink

   OriginalPaper Pages: 369 - 374

10. Extending the cardiovascular benefits of omega-3 fatty acids

    • William S. Harris

    OriginalPaper Pages: 375 - 380

11. Metabolic syndrome: Demographic features, etiology, and clinical management

    • Kathleen L. Wyne

    OriginalPaper Pages: 381 - 388

12. Lipoprotein(a) and atherosclerosis: New perspectives on the mechanism of action of an enigmatic lipoprotein

    • Marlys L. Koschinsky

    OriginalPaper Pages: 389 - 395

13. Pleiotropic effects of fibrates

    • Giulia Chinetti-Gbaguidi
    • Jean Charles Fruchart
    • Bart Staels

    OriginalPaper Pages: 396 - 401